Clinical Lymphoma, Myeloma and Leukemia : Impact Factor & More

eISSN: 2152-2669pISSN: 2152-2650

Check your submission readiness

Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.

Run pre-submission checks

Clinical Lymphoma, Myeloma and Leukemia Key Metrics

CiteScore
3.6
H-Index
60
SJR
Q2Oncology
SNIP
0.78

Clinical Lymphoma, Myeloma and Leukemia Journal Specifications

Overview
Publisher CIG MEDIA GROUP, LP
Language English
Frequency Bi-monthly
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year2010
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Clinical Lymphoma, Myeloma and Leukemia ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Check your researchless than 30 sec
Free Report

Recently Published Papers in Clinical Lymphoma, Myeloma and Leukemia

Moving Towards the Delivery of Outpatient T-Cell Engaging Therapy for the Management of Multiple Myeloma
  • 1 Jun 2025
  • Clinical Lymphoma Myeloma and Leukemia
Identifying Risk Factors and Outcome for CNS involvement in AML
  • 1 Jun 2025
  • Clinical Lymphoma Myeloma and Leukemia
Elderly Acute Lymphoblastic Leukemia: Low-Dose Chemotherapy and Immunotherapy Combinations.
  • 1 Jun 2025
  • Clinical lymphoma, myeloma & leukemia
R-DA-EPOCH versus DA-EPOCH-R: Impact of Chemoimmunotherapy Sequencing on Treatment Outcomes in Patients with Diffuse Large B-cell Lymphoma
  • 1 Jun 2025
  • Clinical Lymphoma Myeloma and Leukemia
Real-World Outcomes of Sequential BCMA-directed therapies inRelapsed Refractory Multiple Myeloma After Belantamab Exposure
  • 1 Jun 2025
  • Clinical Lymphoma Myeloma and Leukemia
SOHO State of the Art Updates and Next Questions | Late/Deferred ASCT in Myeloma.
  • 1 Jun 2025
  • Clinical lymphoma, myeloma & leukemia
Moving Towards the Delivery of Outpatient T-Cell Engaging Therapy for the Management of Multiple Myeloma
  • 1 Jun 2025
  • Clinical Lymphoma Myeloma and Leukemia
Identifying Risk Factors and Outcome for CNS involvement in AML
  • 1 Jun 2025
  • Clinical Lymphoma Myeloma and Leukemia
Elderly Acute Lymphoblastic Leukemia: Low-Dose Chemotherapy and Immunotherapy Combinations.
  • 1 Jun 2025
  • Clinical lymphoma, myeloma & leukemia
R-DA-EPOCH versus DA-EPOCH-R: Impact of Chemoimmunotherapy Sequencing on Treatment Outcomes in Patients with Diffuse Large B-cell Lymphoma
  • 1 Jun 2025
  • Clinical Lymphoma Myeloma and Leukemia
Real-World Outcomes of Sequential BCMA-directed therapies inRelapsed Refractory Multiple Myeloma After Belantamab Exposure
  • 1 Jun 2025
  • Clinical Lymphoma Myeloma and Leukemia
SOHO State of the Art Updates and Next Questions | Late/Deferred ASCT in Myeloma.
  • 1 Jun 2025
  • Clinical lymphoma, myeloma & leukemia
View all papers for this journal

Check if your research matches the topics covered in Clinical Lymphoma, Myeloma and Leukemia?

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Check your research

FAQs on Clinical Lymphoma, Myeloma and Leukemia

Global Journal Library:

Cactus Communications Services Pte Ltd
20 McCallum Street, #19-01, Tokio Marine Centre, Singapore 069046

あなたが夢を実現するまで、そのすべてのステップを共に。論文出版と、その前と後につづく一歩一歩を一緒に歩んでいきます。あなたという、自分自身の研究プロジェクトを超えた大切な存在が「もっと」を手にするために。

お役立ちリンク

Researcher.Lifeにご意見をお寄せください

We are always looking for inspiration, feedback, and collaborators

お問い合わせ

Copyright 2025 Cactus Communications. All rights reserved.

Privacy PolicyCookies PolicyTerms of UseCareers